Division of Communicable and Environmental Diseases and Emergency Preparedness, Tennessee Department of Health, 1st Fl., Cordell Hull Bldg., 425 5th Ave. N., Nashville, TN 37243, USA.
N Engl J Med. 2012 Dec 6;367(23):2194-203. doi: 10.1056/NEJMoa1212972. Epub 2012 Nov 6.
We investigated an outbreak of fungal infections of the central nervous system that occurred among patients who received epidural or paraspinal glucocorticoid injections of preservative-free methylprednisolone acetate prepared by a single compounding pharmacy.
Case patients were defined as patients with fungal meningitis, posterior circulation stroke, spinal osteomyelitis, or epidural abscess that developed after epidural or paraspinal glucocorticoid injections. Clinical and procedure data were abstracted. A cohort analysis was performed.
The median age of the 66 case patients was 69 years (range, 23 to 91). The median time from the last epidural glucocorticoid injection to symptom onset was 18 days (range, 0 to 56). Patients presented with meningitis alone (73%), the cauda equina syndrome or focal infection (15%), or posterior circulation stroke with or without meningitis (12%). Symptoms and signs included headache (in 73% of the patients), new or worsening back pain (in 50%), neurologic symptoms (in 48%), nausea (in 39%), and stiff neck (in 29%). The median cerebrospinal fluid white-cell count on the first lumbar puncture among patients who presented with meningitis, with or without stroke or focal infection, was 648 per cubic millimeter (range, 6 to 10,140), with 78% granulocytes (range, 0 to 97); the protein level was 114 mg per deciliter (range, 29 to 440); and the glucose concentration was 44 mg per deciliter (range, 12 to 121) (2.5 mmol per liter [range, 0.7 to 6.7]). A total of 22 patients had laboratory confirmation of Exserohilum rostratum infection (21 patients) or Aspergillus fumigatus infection (1 patient). The risk of infection increased with exposure to lot 06292012@26, older vials, higher doses, multiple procedures, and translaminar approach to epidural glucocorticoid injection. Voriconazole was used to treat 61 patients (92%); 35 patients (53%) were also treated with liposomal amphotericin B. Eight patients (12%) died, seven of whom had stroke.
We describe an outbreak of fungal meningitis after epidural or paraspinal glucocorticoid injection with methylprednisolone from a single compounding pharmacy. Rapid recognition of illness and prompt initiation of therapy are important to prevent complications. (Funded by the Tennessee Department of Health and the Centers for Disease Control and Prevention.).
我们调查了在接受由一家单一的制剂药房制备的无防腐剂甲基泼尼松龙醋酸酯硬膜外或脊柱旁糖皮质激素注射的患者中发生的中枢神经系统真菌感染爆发。
将病例定义为在硬膜外或脊柱旁糖皮质激素注射后出现真菌性脑膜炎、后循环中风、脊髓骨炎或硬膜外脓肿的患者。提取临床和程序数据。进行队列分析。
66 例病例患者的中位年龄为 69 岁(范围,23 至 91 岁)。从最后一次硬膜外糖皮质激素注射到症状出现的中位时间为 18 天(范围,0 至 56 天)。患者表现为单纯脑膜炎(73%)、马尾综合征或局灶性感染(15%)或后循环中风伴或不伴脑膜炎(12%)。症状和体征包括头痛(73%的患者)、新发或加重背痛(50%)、神经系统症状(48%)、恶心(39%)和颈项强直(29%)。出现脑膜炎、伴有或不伴有中风或局灶性感染的患者第一次腰椎穿刺时的中位脑脊液白细胞计数为 648 个/立方毫米(范围,6 至 10140),其中 78%为粒细胞(范围,0 至 97%);蛋白水平为 114 毫克/分升(范围,29 至 440);葡萄糖浓度为 44 毫克/分升(范围,12 至 121)(2.5mmol/L[范围,0.7 至 6.7])。共有 22 名患者的实验室检测结果证实为喙枝孢(21 名患者)或烟曲霉(1 名患者)感染。感染风险随着接触 06292012@26 批次、较老的小瓶、较高的剂量、多次操作和经皮穿刺硬膜外糖皮质激素注射而增加。伏立康唑用于治疗 61 名患者(92%);35 名患者(53%)还接受了脂质体两性霉素 B 治疗。8 名患者(12%)死亡,其中 7 名患有中风。
我们描述了在接受由一家单一的制剂药房制备的无防腐剂甲基泼尼松龙醋酸酯硬膜外或脊柱旁糖皮质激素注射后的真菌性脑膜炎爆发。快速识别疾病并及时开始治疗对于预防并发症非常重要。(由田纳西州卫生部和疾病控制与预防中心资助)。